@article{0b1c74dd64c64f79bd75186b1b344051,
title = "Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases",
abstract = "A link between histone deacetylases (HDACs) and intestinal inflammation has been established. HDAC inhibitors that target gut-selective inflammatory pathways represent a potential new therapeutic strategy in patients with refractory inflammatory bowel diseases (IBD).",
keywords = "inflammatory bowel disease, therapeutic targets, inflammatory bowel disease, therapeutic targets",
author = "C. Felice and A. Lewis and Alessandro Armuzzi and Lindsay, {J. O.} and A. Silver",
year = "2014",
doi = "10.1111/apt.13008",
language = "English",
volume = "41",
pages = "26--38",
journal = "ALIMENTARY PHARMACOLOGY & THERAPEUTICS",
issn = "0269-2813",
publisher = "Blackwell Science Limited:PO Box 88, Oxford OX2 0NE United Kingdom:011 44 1865 776868, 011 44 1865 206038, EMAIL:
[email protected], INTERNET: http://www.blackwell-science.com, Fax: 011 44 1865 721205",
}